Résultats de la recherche - 4 results
Clinical Evolution and Disease Burden in Belgian Cystic Fibrosis Patients: effect of Newborn Screening?
Annual prevalence of bacterial infections was not different between the 3 patient groups at the predefined time points. Burden of therapy was lower for NBS during the first 2 years of life. Lung function ...
Annual Report Belgian Cystic Fibrosis Registry 2018
of the adults had FEV1 ≥ 90.0% of predicted in 1998 compared to 49.5% and 8.4% in 2010 and 52.4% and 16.4% respectively among the children and adults in 2018. The overall annual prevalence of ...
Annual Report Belgian Cystic Fibrosis Registry 2017
2010 and 54.8% and 11.3% respectively among the children and adults in 2017. The overall annual prevalence of Pseudomonas aeruginosa reported in 2017 was 39.1%. This is the first time the prevalence has ...
The burden of cystic fibrosis in Belgium: a registry-based study
using a prevalence approach (hybrid model) in a multi-aspect disease model. Results: In 2014, patients with cystic fibrosis in Belgium are accountable for 484.8 YLL s and 437.6 YLD s, corresponding with ...